Cargando…

RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma

Identifying prognostic indicators of clear cell renal cell carcinoma (ccRCC) and elucidating the mechanisms underlying ccRCC progression are crucial for improving ccRCC patient prognosis. This study investigated the clinical significance and biological role of Ring finger protein 43 (RNF43) in ccRCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHU, DAWEI, ZHANG, LEI, SHI, XIAOKAI, GAO, SHENGLIN, YUE, CHUANG, ZHANG, LIFENG, BAI, YU, WANG, QIFENG, OKADA, ATSUSHI, YASUI, TAKAHIRO, WANG, CHAO, CUI, XINGANG, ZUO, LI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tech Science Press 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208019/ https://www.ncbi.nlm.nih.gov/pubmed/37304674 http://dx.doi.org/10.32604/or.2022.03458

Ejemplares similares

Combining expression of RNF43 and infiltration level of CD163 (+) tumor associated macrophage predicts prognosis of clear cell renal cell carcinoma
por: Zhu, Dawei, et al.
Publicado: (2022)

ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway
por: Gao, Shenglin, et al.
Publicado: (2021)

A Five Collagen-Related Gene Signature to Estimate the Prognosis and Immune Microenvironment in Clear Cell Renal Cell Cancer
por: Shi, Xiaokai, et al.
Publicado: (2021)

OSM May Serve as a Biomarker of Poor Prognosis in Clear Cell Renal Cell Carcinoma and Promote Tumor Cell Invasion and Migration
por: Wei, Shuzhang, et al.
Publicado: (2023)

Frequent RNF43 mutation contributes to moderate activation of Wnt signaling in colorectal signet-ring cell carcinoma
por: Li, Yaqi, et al.
Publicado: (2020)

Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients
por: Wang, Chao, et al.
Publicado: (2020)

Issues with RNF43 antibodies to reliably detect intracellular location
por: Li, Shanshan, et al.
Publicado: (2023)

miR-483-3p, Mediated by KLF9, Functions as Tumor Suppressor in Testicular Seminoma via Targeting MMP9
por: Zhang, Lei, et al.
Publicado: (2021)

Restoring gluconeogenesis by TEF inhibited proliferation and promoted apoptosis and immune surveillance in kidney renal clear cell carcinoma
por: Zhuang, Wenyuan, et al.
Publicado: (2023)

RNF43 Mutations in IPMN Cases: A Potential Prognostic Factor
por: Chang, Xiao Yan, et al.
Publicado: (2020)

Nuclear Protein 1 Expression Is Associated with PPARG in Bladder Transitional Cell Carcinoma
por: Lu, Chao, et al.
Publicado: (2023)

Identification of Two Wnt-Responsive Elements in the Intron of RING Finger Protein 43 (RNF43) Gene
por: Takahashi, Norihiko, et al.
Publicado: (2014)

Mutated Rnf43 Aggravates Helicobacter Pylori-Induced Gastric Pathology
por: Neumeyer, Victoria, et al.
Publicado: (2019)

Ub and Dub of RNF43/ZNRF3 in the WNT signalling pathway
por: Colozza, Gabriele, et al.
Publicado: (2021)

Deficient Rnf43 potentiates hyperactive Kras‐mediated pancreatic preneoplasia initiation and malignant transformation
por: Zhou, Xian, et al.
Publicado: (2022)

Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
por: Xu, Yingting, et al.
Publicado: (2023)

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma
por: Xie, Ruiyang, et al.
Publicado: (2022)

Protease associated domain of RNF43 is not necessary for the suppression of Wnt/β-catenin signaling in human cells
por: Radaszkiewicz, Tomasz, et al.
Publicado: (2020)

RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis
por: Bond, Catherine E., et al.
Publicado: (2016)

RNF43: A Biomarker With Potential Ramifications for Therapeutic Intervention in Gastric Cancer
por: Noto, Jennifer M., et al.
Publicado: (2020)

RNF43 and ZNRF3 in Wnt Signaling - A Master Regulator at the Membrane
por: Farnhammer, Fiona, et al.
Publicado: (2023)

A deleterious RNF43 germline mutation in a severely affected serrated polyposis kindred
por: Taupin, Douglas, et al.
Publicado: (2015)

An E3 Ubiquitin Ligase RNF139 Serves as a Tumor-Suppressor in Glioma
por: Chen, Xiaofeng, et al.
Publicado: (2021)

The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength
por: de Lau, Wim, et al.
Publicado: (2014)

Loss of RNF43 Function Contributes to Gastric Carcinogenesis by Impairing DNA Damage Response
por: Neumeyer, Victoria, et al.
Publicado: (2020)

RNF43 is associated with genomic features and clinical outcome in BRAF mutant colorectal cancer
por: Shang, Peipei, et al.
Publicado: (2023)

NUPR1 imparts oncogenic potential in bladder cancer
por: Zhang, Lifeng, et al.
Publicado: (2022)

Characterization of RNF43 frameshift mutations that drive Wnt ligand‐ and R‐spondin‐dependent colon cancer
por: Yamamoto, Daisuke, et al.
Publicado: (2022)

Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling
por: Zhong, Weimin, et al.
Publicado: (2021)

Characterization of the RnfB and RnfG Subunits of the Rnf Complex from the Archaeon Methanosarcina acetivorans
por: Suharti, Suharti, et al.
Publicado: (2014)

RNF126 Quenches RNF168 Function in the DNA Damage Response
por: Zhang, Lianzhong, et al.
Publicado: (2018)

RNF43 truncations trap CK1 to drive niche‐independent self‐renewal in cancer
por: Spit, Maureen, et al.
Publicado: (2020)

A phospho-switch controls RNF43-mediated degradation of Wnt receptors to suppress tumorigenesis
por: Tsukiyama, Tadasuke, et al.
Publicado: (2020)

RNF43 mutation analysis in serrated polyposis, sporadic serrated polyps and Lynch syndrome polyps
por: van Herwaarden, Yasmijn J, et al.
Publicado: (2020)

A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors
por: Hijikata, Yasuki, et al.
Publicado: (2018)

RT-qPCR analysis of the tumor antigens TOMM34 and RNF43 in samples extracted from paraffin-embedded specimens of colorectal cancer
por: Matsushita, Norimasa, et al.
Publicado: (2017)

RNF43 ubiquitinates and degrades phosphorylated E-cadherin by c-Src to facilitate epithelial-mesenchymal transition in lung adenocarcinoma
por: Zhang, Yunfeng, et al.
Publicado: (2019)

KRAS, GNAS, and RNF43 mutations in intraductal papillary mucinous neoplasm of the pancreas: a meta-analysis
por: Lee, Ju-Han, et al.
Publicado: (2016)

RNF43 overexpression attenuates the Wnt/β-catenin signalling pathway to suppress tumour progression in cholangiocarcinoma
por: Pangestu, Norma Sainstika, et al.
Publicado: (2021)

Exome sequencing revealed comparable frequencies of RNF43 and BRAF mutations in Middle Eastern colorectal cancer
por: Siraj, Abdul Khalid, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_asfr5ikjv0alkqbf2djbb08tmo